Abstract
Tacrolimus is the new name for the Japanese immunosuppressant drug FK506. It blocks interleukin 2 transcription thereby inhibiting the CD4 Th-1 lymphocyte response to foreign antigens. It also selectively inhibits cytokine secretion of IL3, IL4 and interferon-gamma. It is metabolised by the cytochrome P-450 enzyme system. The results of two trials indicate that it is similar to cyclosporin in efficacy and toxicity.
Full text
PDFPage 586
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med. 1994 Oct 27;331(17):1110–1115. doi: 10.1056/NEJM199410273311702. [DOI] [PubMed] [Google Scholar]
- Ishioka M., Ohno S., Nakamura S., Isobe K., Watanabe N., Ishigatsubo Y., Tanaka S. FK506 treatment of noninfectious uveitis. Am J Ophthalmol. 1994 Dec 15;118(6):723–729. doi: 10.1016/s0002-9394(14)72551-6. [DOI] [PubMed] [Google Scholar]